Fairfield County, CT - Senator Tony Hwang (R-28) is staying apprised of the state and national happenings regarding the safety and efficient rollout and delivery of the Pfizer Covid-19 vaccines.
Sen. Hwang, as co-chair of CT Bioscience Caucus, joined Pfizer medical research officials in their update forum with State of Maine Public Health, Medical Staff and Healthcare providers to better learn about the research and testing methodology and equally important, their process for delivery of vaccines throughout the world.
Hwang was eager to learn what protocols Connecticut may (or may not) want to follow as Connecticut’s Vaccine Distribution Task Force prepares to establish guidelines and priorities for Covid-19 vaccines to be distributed and delivered throughout Connecticut.
Last week, Pfizer announced that they are making incredible progress developing a vaccine for Covid-19 and pending U.S. Food and Drug Administration's (FDA) Emergency Use Authorization (EUA) for approved medical vaccination use as early as early December.
“I applaud the research and development teams at Pfizer, BioNTech and other BioCT operations who are leading the nation on establishing a safe, effective vaccine for Covid-19.
“I want to thank the U.S. Food and Drug Administration for their efforts in expediting the “Emergency Use Authorization” approval process for these very important vaccines while not compromising on the quality of the medicine or testing requirements.
“Seeing the early feedback from hospitals and medical experts has been very enlightening both in the developments and strategies with managing and safely distributing an effective vaccine. This is an exciting but challenging time for the bioscience sector to implement a worldwide vaccine distribution plan. The best thing we can do as state leaders is to be informed and confident in how we communicate medically based facts to the public and ensure information and education are readily available to the public.
“I pledge to follow the conversation on guidance or updates on the Covid-19 vaccine so Connecticut residents will have a clear understanding of the status and effectiveness of this potential protection,” said Sen. Hwang.